We use analytics to improve your experience. Cookie policy
NYSE · HEALTHCARE · Forecast
Wall Street targets, TECHi-approved analyst sentiment, and bull / base / bear scenarios on TMO.
Wall Street · Analyst views
Ratings, price targets, and the recommendation mix for the next 12 months.
Analysts tracked
26
Rating score
4.12
Median target
Not available
Consensus target
$620.12
+34.05% from current
Median target
—
High target
—
Low target
—
Scenario framing
Base case
$620.12
+34.05% from current
Consensus 12-month target. Reflects the average of every published sell-side model — the median expectation for TMO's next year.
Recommendation mix
Strong Buy
5
19% of 26
Buy
19
73% of 26
Hold
2
8% of 26
Sell
0
0% of 26
Strong Sell
0
0% of 26
Frequently asked
Wall Street analyst targets and the TECHi analyst consensus for Thermo Fisher Scientific Inc. are tracked on the TECHi TMO forecast page, with separate bull / base / bear scenarios.
Thermo Fisher Scientific Inc. ratings are tracked across TECHi-approved analysts and the broader Street. The forecast page shows the % bullish / hold / bearish split and links to the underlying analysis.
Twelve-month price targets — the median Wall Street target and the TECHi desk's bull / base / bear scenarios — are published on the TECHi TMO forecast page.
TECHi tracks every public price target it issues and grades them at 30, 90, and 180 days. Per-author accuracy is published on each analyst's profile.
